SEC Form 3 · accession 0001683168-18-002753
CV Sciences, Inc. · CVSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph C Maroon M.D.
Director
Period of report
Aug 4, 2018
Accepted (ET)
Sep 14, 2018 · 1:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510964
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 639,891 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.95 | holding | — | — | — | — | Aug 3, 2028 | Common Stock | 250,000 | — | D |
Explanation of responses
- F1The option is durational-based. 50,000 option shares are fully-vested on the Date of Grant and the remaining option shares vest and become exercisable in twenty-four (24) successive equal monthly installments, commencing on August 4, 2018.